Axsome Therapeutics Free Cash Flow (Quarterly) Insights

Axsome Therapeutics Inc (AXSM)

74.17 -0.72 (-0.96%) USD | NASDAQ | May 02, 16:00

74.17 0.00 (0.00%) After-Hours: 20:00

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-30.37M
September 30, 2023	-53.92M
June 30, 2023	-55.48M
March 31, 2023	-5.892M
December 31, 2022	-27.74M
September 30, 2022	-22.82M
June 30, 2022	-33.78M
March 31, 2022	-32.87M
December 31, 2021	-28.84M
September 30, 2021	-27.03M
June 30, 2021	-25.41M
March 31, 2021	-27.25M
December 31, 2020	-20.57M
September 30, 2020	-15.75M
June 30, 2020	-18.90M
March 31, 2020	-23.28M
December 31, 2019	-17.57M
September 30, 2019	-10.63M

Date	Value
June 30, 2019	-8.693M
March 31, 2019	-9.499M
December 31, 2018	-9.794M
September 30, 2018	-5.920M
June 30, 2018	-7.677M
March 31, 2018	-6.695M
December 31, 2017	-6.291M
September 30, 2017	-6.451M
June 30, 2017	-7.10M
March 31, 2017	-6.639M
December 31, 2016	-7.223M
September 30, 2016	-4.879M
June 30, 2016	-5.326M
March 31, 2016	-3.958M
December 31, 2015	-2.255M
September 30, 2015	-1.927M
June 30, 2015	-2.108M
March 31, 2015	-1.169M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-55.48M

Minimum

Jun 2023

-5.892M

Maximum

Mar 2023

-25.62M

Average

-25.41M

Median

Jun 2021

Free Cash Flow (Quarterly) Benchmarks